Abstract
It is clinically possible for patients with Alport syndrome (AS) to suffer from poststreptococcal acute glomerulonephritis (PSAGN). However, there is only one report of such a patient, and he had end-stage kidney disease. Here, we describe an 8-year-old male with X-linked AS and chronic kidney disease (CKD) stage G2. He presented with diffuse edema, gross hematuria, proteinuria, and body weight gain after streptococcal pharyngitis. Blood examination showed kidney dysfunction, hypocomplementemia, and increased anti-streptolysin-O levels. His kidney function did not improve with symptomatic treatment. Therefore, we started steroid administration on the 12th day of hospitalization. Then, his kidney function improved before he was discharged. We confirmed that his complement function had recovered at a later date. Pathological evaluation showed findings of AS and PSAGN, including cellular crescents in 3/30 glomeruli on light microscopy. In addition, electron dense deposits (EDDs) were seen in not only the visceral subepithelium but also the glomerular basement intramembrane and subendothelium, some of which were hump-like. Although AS and CKD are indicated to have a poor prognosis in PSAGN, our patient recovered after administration of steroids. Our case suggests that we can consider the administration of steroids, including pulse therapy for PSAGN, when patients have, for example, crescents on pathology, severe renal dysfunction, nephrotic proteinuria, or AS with CKD, as in our case. Kidney pathology suggested that a typical hump is not seen in patients with cooccurring AS and PSAGN. After the patient’s kidney function recovered, we continued to follow him.
Similar content being viewed by others
References
Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T, et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol. 2019;23:158–68.
Demircioglu Kılıc B, Akbalık Kara M, Buyukcelik M, Balat A. Pediatric post-streptococcal glomerulonephritis: clinical and laboratory data. Pediatr Int. 2018;60:645–50.
Tasic V, Ristoska-Bojkovska N, Gucev Z, Lozanovski VJ. Poststreptococcal glomerulonephritis in children with congenital anomalies of the kidney and urinary tract. Ren Fail. 2015;37:1440–3.
Horita Y, Tadokoro M, Taura K, Suyama N, Taguchi T, Miyazaki M, et al. Histologically confirmed superimposition of post-streptococcal acute glomerulonephritis during IgA nephropathy. Clin Exp Nephrol. 2004;8:351–5.
Fujinaga S, Ohtomo Y, Mochizuki H, Murakami H, Shimizu T, Yamashiro Y, et al. Rapidly progressive acute post-streptococcal glomerulonephritis in a child with IgA nephropathy. Pediatr Int. 2009;51:425–8.
Araki Y, Kawaguchi A, Sakakibara N, Nagaoka Y, Yamamura T, Horinouchi T, et al. Poststreptococcal acute glomerulonephritis can be a risk factor for accelerating kidney dysfunction in Alport syndrome: a case experience. CEN Case Rep. 2020;9:418–22.
Zaffanello M, Cataldi L, Franchini M, Fanos V. Evidence-based treatment limitations prevent any therapeutic recommendation for acute poststreptococcal glomerulonephritis in children. Med Sci Monit. 2010;16:RA79-84.
Yano K, Suzuki H, Oda T, Ueda Y, Tsukamoto T, Muso E. Crescentic poststreptococcal acute glomerulonephritis accompanied by small vessel vasculitis: case report of an elderly male. BMC Nephrol. 2019;20:471.
Yang TJ, Shah H, Olagunju A, Novak M, Difilippo W. Role of steroids in post-streptococcal glomerulonephritis without crescents on renal biopsy. Cureus. 2018;10:e3150.
Yamakami K, Yoshizawa N, Wakabayashi K, Takeuchi A, Tadakuma T, Boyle MD. The potential role for nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis. Methods. 2000;21:185–97.
Uchida T, Oda T, Watanabe A, Izumi T, Higashi K, Kushiyama T, et al. Clinical and histologic resolution of poststreptococcal glomerulonephritis with large subendothelial deposits and kidney failure. Am J Kidney Dis. 2011;58:113–7.
Jones M, Tomson C. Acute kidney injury and “nephrotoxins”: mind your language. Clin Med (Lond). 2018;18:384–6.
Funding
We have no funding to declare.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest.
Ethical approval
Not applicable.
Informed consent
Informed consent was obtained from the patient in this report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Suzuki, R., Hayashi, A., Endo, M. et al. Cooccurrence of Alport syndrome and poststreptococcal acute glomerulonephritis with improvement after steroid administration. CEN Case Rep 11, 453–457 (2022). https://doi.org/10.1007/s13730-022-00699-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-022-00699-x